Elon Musk's recent holiday post reveals he has been using an anti-obesity drug, highlighting the mainstream acceptance of weight-loss medications like Ozempic and Wegovy among public figures.
As weight-loss drugs rise in popularity, the unique class of GLP-1 agonists such as Mounjaro and Ozempic are becoming essential for those with obesity and diabetes.
Public figures openly discussing their weight-loss drug use is reshaping societal perceptions around obesity, pushing the conversation towards understanding their broader health implications.
Musk emphasized the need for affordable access to GLP inhibitors, stating that they could significantly enhance the health and longevity of the American populace.
Collection
[
|
...
]